Iondom Capsule SR is a combination pharmaceutical formulation containing Domperidone 30mg and Esomeprazole 40mg, designed for the management of gastrointestinal disorders. Domperidone, a peripheral dopamine D2 receptor antagonist, facilitates gastric motility and accelerates gastric emptying, thereby alleviating symptoms such as nausea, vomiting, and bloating associated with delayed gastric emptying and gastroparesis. Esomeprazole, a proton pump inhibitor (PPI), suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system in the gastric parietal cells, providing effective relief from acid-related conditions including gastroesophageal reflux disease (GERD), erosive esophagitis, and peptic ulcers. The sustained-release formulation ensures prolonged therapeutic plasma concentrations, enhancing efficacy and patient compliance by reducing dosing frequency. Iondom Capsule SR is indicated for patients requiring combined prokinetic and acid-suppressive therapy, particularly in cases where symptoms of acid reflux coexist with delayed gastric emptying. It should be used under medical supervision, with caution advised in patients with cardiac disorders due to Domperidone’s potential to prolong QT interval. Common adverse effects may include headache, dry mouth, and gastrointestinal disturbances. Contraindications include hypersensitivity to any component and concurrent use with drugs known to prolong QT interval.